Literature DB >> 32838278

Racial and ethnic disparity and spatiotemporal trends in severe acute respiratory syndrome coronavirus 2 prevalence on obstetrical units in New York.

Matthew J Blitz1, Burton Rochelson1, Lakha Prasannan1, Weiwei Shan1, Frank A Chervenak1, Michael Nimaroff1, Eran Bornstein1.   

Abstract

Entities:  

Year:  2020        PMID: 32838278      PMCID: PMC7429514          DOI: 10.1016/j.ajogmf.2020.100212

Source DB:  PubMed          Journal:  Am J Obstet Gynecol MFM


× No keyword cloud information.

Objective

Coronavirus disease 2019 (COVID-19), caused by the virus known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), affects racial and ethnic minorities and socioeconomically disadvantaged groups disproportionately.1, 2, 3 It remains uncertain how the proportions of positive SARS-CoV-2 test results have changed over time among pregnant women from socially vulnerable populations after the closure of nonessential businesses and schools, and promotion of social distancing measures. We evaluated the temporal trends, regional geographic variation, and racial and ethnic disparity in SARS-CoV-2 prevalence among pregnant women presenting to obstetrical units of a large health system in New York during the COVID-19 outbreak.

Study Design

This retrospective study included all pregnant women who were tested for SARS-CoV-2 (both symptomatic and asymptomatic) at 7 hospitals within a 30-mile radius from April 1, 2020, before the peak of the outbreak in New York State, to June 9, 2020. These facilities, located in New York City and Long Island, include tertiary academic medical centers as well as community hospitals. The population served is one of the most diverse worldwide; the patients reside in both urban and suburban communities and are representative of a wide socioeconomic spectrum. To reduce the occult transmission of the virus from asymptomatic or presymptomatic carriers, universal SARS-CoV-2 testing protocols were implemented in all obstetrical units at the beginning of the 10-week study period, with the exception of 2 hospitals, namely Lenox Hill Hospital (LHH) and Staten Island University Hospital (SIUH), which started universal testing in weeks 2 and 4, respectively. Polymerase chain reaction (PCR) testing was performed using nasopharyngeal swabs; patients were excluded if the results were not available or, for LHH and SIUH, if they were performed before the implementation of universal testing. Data analyzed in this study included the SARS-CoV-2 test results, race and ethnicity, delivery hospital, and week of hospital visit. The weekly temporal trends in SARS-CoV-2 prevalence were compared among obstetrical units and across racial and ethnic groups. The Cochran-Armitage trend test was used to evaluate the significance of the trends in the number of positive cases over time. Multiple logistic regression analysis was used to model the binary outcome of having a positive or negative PCR result using time (study week), race and ethnicity, hospital site, and their correlations as predictors. The Northwell Health Institutional Review Board approved this study as a minimal-risk research study using data collected as part of routine clinical practice, and therefore waived the requirement for informed consent.

Results

Of the 4811 pregnant women presenting to the 7 hospital sites after implementation of universal SARS-CoV-2 testing, PCR test results were obtained for 4674 patients—500 (11%) were positive. The test results were not available for 3% (n=137) of the patients, either because the test was not performed or because it was performed offsite and the result was not retrievable via our electronic medical record systems. The overall prevalence of the virus across the health system’s obstetrical units declined from 25% in the 1st week to 4% in the 10th week; the trend of a decrease in the number of positive PCR tests over time was statistically significant (P<.0001). Differences in the number of positive SARS-CoV-2 tests were observed between racial and ethnic groups (P<.0001). Hispanic women constituted 18% (n=836) of the study population but accounted for 31% of all the positive tests, with a test positivity rate of 18% (n=153); this was the most affected ethnic group in the study. Non-Hispanic black women, who constituted 12% (n=567) of the study population, had a test positivity rate of 14% (n=77) and accounted for 15% of all the positive tests. Non-Hispanic white women, the largest racial or ethnic group, constituted 44% (n=2065) of the patients, had a test positivity rate of 8% (n=167), and accounted for 33% of all the positive tests. Asian women comprised 13% (n=589) of the population and were the least affected group, with a test positivity rate of 5% (n=32); they accounted for 6% of all the positive tests. Women in the other or multiracial group comprised 13% (n=617) of the population, had a test positivity rate of 12% (n=71), and accounted for 14% of all the positive tests. The proportion of women in each racial or ethnic group varied by hospital site (Figure, A ). Each racial or ethnic group had a significant decrease in the number of positive PCR tests over time (P<.0001), and logistic regression analysis showed that the rates of decline were similar among groups (Figure, B).
Figure

Racial and ethnic disparity and spatiotemporal variation in SARS-CoV-2 prevalence

A, Race/ethnicity of pregnant women presenting to obstetrical units within Northwell Health from April 1 to June 9, 2020, stratified by hospital site. B, Temporal changes in the prevalence of SARS-CoV-2 among pregnant women presenting to obstetrical units within Northwell Health from April 1 to June 10, 2020, stratified by race/ethnicity. No significant difference in the rate of decline was observed among groups.

PCR, polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Blitz. Spatiotemporal trends in SARS-CoV-2. AJOG MFM 2020.

Racial and ethnic disparity and spatiotemporal variation in SARS-CoV-2 prevalence A, Race/ethnicity of pregnant women presenting to obstetrical units within Northwell Health from April 1 to June 9, 2020, stratified by hospital site. B, Temporal changes in the prevalence of SARS-CoV-2 among pregnant women presenting to obstetrical units within Northwell Health from April 1 to June 10, 2020, stratified by race/ethnicity. No significant difference in the rate of decline was observed among groups. PCR, polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. Blitz. Spatiotemporal trends in SARS-CoV-2. AJOG MFM 2020. Considerable heterogeneity in SARS-CoV-2 prevalence was observed across hospitals in the region (P<.0001; Table ). Overall, test positivity ranged from 6% to 19% across obstetrical units, and the peak prevalence at each site varied from 13% to 41%. A significant decrease in the number of positive tests weekly was observed at all sites, but the rate of decline was significantly higher at some sites compared with others. A correlation between the site and race or ethnicity was not detected.
Table

Temporal changes in the SARS-CoV-2 test results on presentation to obstetrical units of Northwell Health from April 1 to June 9, 2020, stratified by hospital site

CharacteristicsSARS-CoV-2 PCR results by week, n (%)
Week 1April1–7Week 2April8–14Week 3April15–21Week 4April22–28Week 5April 29–May 5Week 6May6–12Week 7May13–19Week 8May20–26Week 9May 27–June 2Week 10June3–9Total
All hospitals
Total4074304305024814754944705104754674
 Positive103 (25)57 (13)57 (13)76 (15)50 (10)51 (11)37 (7)23 (5)28 (5)18 (4)500 (11)
 Negative304 (75)373 (87)373 (87)426 (85)431 (90)424 (89)457 (93)447 (95)482 (95)457 (96)4174 (89)
North Shore University Hospital, Manhasset, NY
Total119116112116115961151191401051153
 Positive15 (13)11 (9)13 (12)10 (9)7 (6)1 (1)6 (5)1 (1)5 (4)2 (2)71 (6)
 Negative104 (87)105 (91)99 (88)106 (91)108 (94)95 (99)109 (95)118 (99)135 (96)103 (98)1082 (94)
Long Island Jewish Medical Center, New Hyde Park, NY
Total1761391251281281571391431431211399
 Positive51 (29)19 (14)18 (14)23 (18)13 (10)15 (10)10 (7)7 (5)4 (3)4 (3)164 (12)
 Negative125 (71)120 (86)107 (86)105 (82)115 (90)142 (90)129 (93)136 (95)139 (97)117 (97)1235 (88)
Southside Hospital, Bay Shore, NY
Total49484038413348374243418
 Positive20 (41)14 (29)5 (13)2 (5)7 (17)6 (18)8 (17)3 (8)2 (5)2 (5)69 (17)
 Negative29 (59)34 (71)35 (87)36 (95)34 (83)27 (82)40 (83)34 (92)40 (95)41 (95)349 (83)
Huntington Hospital, Huntington, NY
Total38203731342732201939297
 Positive8 (21)2 (10)7 (19)4 (13)1 (3)2 (7)0 (0)0 (0)1 (5)1 (3)26 (9)
 Negative30 (89)18 (90)30 (81)27 (87)33 (97)25 (93)32 (100)20 (100)18 (95)38 (97)271 (91)
Long Island Jewish Forest Hills, Forest Hills, NY
Total25433842444438283940381
 Positive9 (36)6 (14)10 (26)10 (24)8 (18)9 (20)5 (13)2 (7)8 (21)4 (10)71 (19)
 Negative16 (64)37 (86)28 (74)32 (76)36 (82)35 (80)33 (87)26 (93)31 (79)36 (90)310 (81)
Lenox Hill Hospital, Manhattan, NYa
Total-647882746870727983670
 Positive-5 (8)4 (5)11 (13)2 (3)11 (16)2 (3)2 (3)1 (1)1 (1)39 (6)
 Negative-59 (92)74 (95)71 (87)72 (97)57 (84)68 (97)70 (97)78 (99)82 (99)631 (94)
Staten Island University Hospital, Staten Island, NYb
Total---65455052514944356
 Positive---16 (25)12 (27)7 (14)6 (12)8 (16)7 (14)4 (10)60 (17)
 Negative---49 (75)33 (73)43 (86)46 (88)43 (84)42 (86)40 (90)296 (83)

PCR, polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Blitz. Spatiotemporal trends in SARS-CoV-2. AJOG MFM 2020.

Universal SARS-CoV-2 PCR testing protocol implemented during the second week of the study period

Universal SARS-CoV-2 PCR testing protocol implemented during the fourth week of the study period.

Temporal changes in the SARS-CoV-2 test results on presentation to obstetrical units of Northwell Health from April 1 to June 9, 2020, stratified by hospital site PCR, polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. Blitz. Spatiotemporal trends in SARS-CoV-2. AJOG MFM 2020. Universal SARS-CoV-2 PCR testing protocol implemented during the second week of the study period Universal SARS-CoV-2 PCR testing protocol implemented during the fourth week of the study period.

Conclusion

Within a large health system in New York, Hispanic and non-Hispanic black pregnant women were disproportionately affected by SARS-CoV-2; despite constituting approximately one-third of the study population, they accounted for nearly half of all the cases. Although a decrease in the prevalence of the virus was observed in all racial and ethnic groups during the 10-week study period, there was no difference in the rate of decline among the groups. This may indicate that all the groups benefited from the implementation of social distancing measures despite a legitimate concern that vulnerable populations may have greater difficulty in adhering to such guidelines. Geographic variability in positive SARS-CoV-2 cases results in high and low prevalence obstetrical units, which has implications for healthcare resource planning and community outreach, education, and prevention efforts. A statistically significant decrease in the number of positive cases over time was observed across all obstetrical units during the study period, but the rate of change was not uniform, with the rates declining more rapidly in some sites than others. An evaluation of the factors that contribute to this variation is therefore warranted. Universal testing protocols in obstetrical units may allow for the identification of spatiotemporal trends in SARS-CoV-2 prevalence that reflect the surrounding catchment areas, providing a dynamic view of viral spread in our communities.
  2 in total

1.  Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) Illness in Symptomatic Pregnant and Postpartum Women Stratified by Hispanic Ethnicity.

Authors:  Ilona Telefus Goldfarb; Mark A Clapp; Marti D Soffer; Lydia L Shook; Katherine Rushfirth; Andrea G Edlow; Adeline A Boatin; Anjali J Kaimal; William H Barth; Allison S Bryant
Journal:  Obstet Gynecol       Date:  2020-08       Impact factor: 7.623

2.  Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.

Authors:  Shikha Garg; Lindsay Kim; Michael Whitaker; Alissa O'Halloran; Charisse Cummings; Rachel Holstein; Mila Prill; Shua J Chai; Pam D Kirley; Nisha B Alden; Breanna Kawasaki; Kimberly Yousey-Hindes; Linda Niccolai; Evan J Anderson; Kyle P Openo; Andrew Weigel; Maya L Monroe; Patricia Ryan; Justin Henderson; Sue Kim; Kathy Como-Sabetti; Ruth Lynfield; Daniel Sosin; Salina Torres; Alison Muse; Nancy M Bennett; Laurie Billing; Melissa Sutton; Nicole West; William Schaffner; H Keipp Talbot; Clarissa Aquino; Andrea George; Alicia Budd; Lynnette Brammer; Gayle Langley; Aron J Hall; Alicia Fry
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-17       Impact factor: 17.586

  2 in total
  4 in total

1.  The association between maternal characteristics and SARS-CoV-2 in pregnancy: a population-based registry study in Sweden and Norway.

Authors:  Anne K Örtqvist; Maria C Magnus; Jonas Söderling; Laura Oakley; Anne-Marie Nybo Andersen; Siri E Håberg; Olof Stephansson
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

Review 2.  Health Care Disparities in the COVID-19 Pandemic in the United States: A Focus on Obstetrics.

Authors:  Ukachi N Emeruwa; Cynthia Gyamfi-Bannerman; Russell S Miller
Journal:  Clin Obstet Gynecol       Date:  2022-03-01       Impact factor: 2.190

Review 3.  The Epidemiology of COVID-19 in Pregnancy.

Authors:  Eve E Overton; Dena Goffman; Alexander M Friedman
Journal:  Clin Obstet Gynecol       Date:  2022-03-01       Impact factor: 2.190

Review 4.  Social Determinants of Disease: HIV and COVID-19 Experiences.

Authors:  Raiza M Beltran; Ian W Holloway; Chenglin Hong; Ayako Miyashita; Luisita Cordero; Elizabeth Wu; Katherine Burris; Paula M Frew
Journal:  Curr HIV/AIDS Rep       Date:  2022-02-02       Impact factor: 5.071

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.